Exercise-rest Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: Direct comparison with Tl-201 reinjection

Journal of Nuclear Cardiology

Volumn 6, Issue 3, 1999, Pages 270-277

  Nicolai, Emanuele ^b   Cuocolo, Alberto ^a   Acampa, Wanda ^b   Varrone, Andrea ^b   Pace, Leonardo ^b   Salvatore, Marco ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

Myocardial infarction; Myocardial perfusion; Myocardial viability

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; HEART; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; MIDDLE AGED; SCINTISCANNING; STATISTICAL ANALYSIS;

ADULT; CORONARY CIRCULATION; DATA INTERPRETATION, STATISTICAL; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032589129     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90038-7     Document Type: Article

References (29)

1. Kelly DJ, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
2. Nakajima BS, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m-tetrofosmin. J Nucl Med 1993;34:1478-84.
3. Sridara B, Sochor H, Rigo P, et al. Myocardial single-photon emission computed tomographic imaging with technetium-99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging. J Nucl Cardiol 1994;1:138-43.
4. Cuocolo A, Soricelli A, Nicolai E, et al. Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery stenosis in previous myocardial infarction. J Nucl Med 1995;36:907-13.
5. Flamen P, Bossuyt A, Franken PR. Technetium-99m tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m sestamibi. J Nucl Med 1995;36:2009-15.
6. Acampa W, Cuocolo A, Sullo P, et al. Direct comparison of technetium-99m sestamibi and technetium-99m tetrofosmin cardiac single-photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998;5:265-74.
7. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587-93.
8. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
9. Matsunari I, Fujino S, Taki J, et al. Myocardial viability assessment with technetium-99m tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995;36:1961-7.
10. Cuocolo A, Soricelli A, Pace L, et al. Adenosine Tc-99m methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise. J Nucl Med 1994;35:1110-5.
11. Sullo P, Cuocolo A, Nicolai E, et al. Quantitative exercise technetium-99m tetrofosmin myocardial tomography for the identification and localization of coronary artery disease. Eur J Nucl Med 1996;23:648-55.
12. Petretta M, Cuocolo A, Bonaduce D, et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med 1997;38:195-200.
13. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m methoxy isobutyl isonitrile tomography after nitrates administration in patients with chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
14. Shiller NB, Shah PM, Crawford M, et al. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo 1989;2:358-67.
15. Pozzoli M, Fioretti PM, Salustri A, Reijs AEM, Roelandt JR. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol 1991;67:350-5.
16. Volpe M, Rao MAE, Cuocolo A, et al. Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Circulation 1995;92:2511-8.
17. Heo J, Cave V, Wasserleben V, Iskandrian AS. Planar and tomographic imaging with technetium 99m-labeled tetrofosmin: correlation with thallium 201 and coronary angiography. J Nucl Cardiol 1994;1:317-24.
18. Dahlberg ST, Gilmore MP, Leppo JA. Effects of coronary blood flow on the "uptake" of tetrofosmin in isolated rabbit heart [abstract]. J Nucl Med 1992;33:846.
19. Koplan BA, Belier GA, Ruiz M, Yang JY, Watson DD, Glover DK. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med 1996;37:1398-402.
20. Galassi AR, Tamburino C, Grassi R, et al. Comparison of technetium-99m tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. J Nucl Cardiol 1998;5:56-63.
21. Matsunari I, Fujino S, Taki J, et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with restredistribution thallium-201. J Am Coll Cardiol 1997;29:1226-33.
22. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with Tl-201 and Tc-99m sestamibi. Circulation 1994;89:2552-61.
23. Younes A, Songadele JA, Plats E, Pickett R, Maublant JC, Veire A. Mechanism of uptake of technetium tetrofosmin: II - uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995;2:324-33.
24. Plats EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin - I: uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995;2:317-26.
25. Younès A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995;2:327-33.
26. Rocco TP, Dilsizian V, McKusick KA, Fishman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-63.
27. Dilsizian V, Rocco TO, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
28. Tamaki N, Ohtani H, Yonekura Y, et al. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-23.
29. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18-F-fluorodeoxiglucose. Circulation 1991;83:26-37.